Your browser doesn't support javascript.
loading
Spontaneous Glycan Reattachment Following N-Glycanase Treatment of Influenza and HIV Vaccine Antigens.
Keating, Celina L; Kuhn, Eric; Bals, Julia; Cocco, Alexandra R; Yousif, Ashraf S; Matysiak, Colette; Sangesland, Maya; Ronsard, Larance; Smoot, Matthew; Moreno, Thalia Bracamonte; Okonkwo, Vintus; Setliff, Ian; Georgiev, Ivelin; Balazs, Alejandro B; Carr, Steven A; Lingwood, Daniel.
Afiliação
  • Keating CL; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Kuhn E; The Broad Institute of The Massachusetts Institute of Technology and Harvard University , 415 Main Street , Cambridge , Massachusetts 02142 , United States of America.
  • Bals J; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Cocco AR; The Broad Institute of The Massachusetts Institute of Technology and Harvard University , 415 Main Street , Cambridge , Massachusetts 02142 , United States of America.
  • Yousif AS; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Matysiak C; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Sangesland M; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Ronsard L; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Smoot M; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Moreno TB; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Okonkwo V; The Ragon Institute of Massachusetts General Hospital , The Massachusetts Institute of Technology and Harvard University , 400 Technology Square , Cambridge , Massachusetts 02139 , United States of America.
  • Setliff I; Program in Chemical & Physical Biology , Vanderbilt University Medical Center , 340 Light Hall , Nashville 37232-0301 , United States of America.
  • Georgiev I; Vanderbilt Vaccine Center , Vanderbilt University , 2213 Garland Avenue , Nashville , Tennessee 37232-0417 , United States of America.
  • Balazs AB; Program in Chemical & Physical Biology , Vanderbilt University Medical Center , 340 Light Hall , Nashville 37232-0301 , United States of America.
  • Carr SA; Vanderbilt Vaccine Center , Vanderbilt University , 2213 Garland Avenue , Nashville , Tennessee 37232-0417 , United States of America.
  • Lingwood D; Department of Pathology, Microbiology, and Immunology , Vanderbilt University Medical Center , C-3322 Medical Center North , Nashville , Tennessee 37232-2561 , United States of America.
J Proteome Res ; 19(2): 733-743, 2020 02 07.
Article em En | MEDLINE | ID: mdl-31913636
ABSTRACT
In cells, asparagine/N-linked glycans are added to glycoproteins cotranslationally, in an attachment process that supports proper folding of the nascent polypeptide. We found that following pruning of N-glycan by the amidase PNGase F, the principal influenza vaccine antigen and major viral spike protein hemagglutinin (HA) spontaneously reattached N-glycan to its de-N-glycosylated positions when the amidase was removed from solution. This reaction, which we term N-glycanation, was confirmed by site-specific analysis of HA glycoforms by mass spectrometry prior to PNGase F exposure, during exposure to PNGase F, and after amidase removal. Iterative rounds of de-N-glycosylation followed by N-glycanation could be repeated at least three times and were observed for other viral glycoproteins/vaccine antigens, including the envelope glycoprotein (Env) from HIV. Covalent N-glycan reattachment was nonenzymatic as it occurred in the presence of metal ions that inhibit PNGase F activity. Rather, N-glycanation relied on a noncovalent assembly between protein and glycan, formed in the presence of the amidase, where linearization of the glycoprotein prevented this retention and subsequent N-glycanation. This reaction suggests that under certain experimental conditions, some glycoproteins can organize self-glycan addition, highlighting a remarkable self-assembly principle that may prove useful for re-engineering therapeutic glycoproteins such as influenza HA or HIV Env, where glycan sequence and structure can markedly affect bioactivity and vaccine efficacy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Vacinas contra a AIDS / Influenza Humana Limite: Humans Idioma: En Revista: J Proteome Res Assunto da revista: BIOQUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Vacinas contra a AIDS / Influenza Humana Limite: Humans Idioma: En Revista: J Proteome Res Assunto da revista: BIOQUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos